Medicus Pharma (MDCX) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

—

Revenue (quarter)

—

Revenue growth (year over year)

—

Gross profit (trailing twelve months)

—

Gross margin

—

Net income (trailing twelve months)

—

Net income (quarter)

−$11.7M

Net income growth (year over year)

−89.19%

Net margin

—

Return on equity

−7631.06%

EPS (trailing twelve months)

−$2.36

Book value per share

−$0.03

P/E (trailing twelve months)

—

Price to book

—

Debt to assets

106.36%

Payout ratio

—

Dividend yield

—

Company profile

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

• How do I buy stock in Medicus Pharma (MDCX)?

  MDCX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.